Drugs / Pyronaridine Tetraphosphate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/31 trial · 1 met primary | ||||||
| Phase 2/3 | NCT04049916 | Sep 2019 → Jan 2020 | Plasmodium falciparum malaria | London School of Hygiene and Tropical Medicine | Completed | Met primary |
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT05441410 Background | Jun 2025 → Jun 2026 overdue | malaria | University Hospital Tuebingen | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pyronaridine Tetraphosphate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05441410 ↗ |